A new FDA-approved sublingual form of cyclobenzaprine HCl shows promising efficacy and tolerability in fibromyalgia.
Tracey Mahvan, RPh, PharmD, BCGP
Advertisement
Articles by Tracey Mahvan, RPh, PharmD, BCGP
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Reformulated Ranitidine After 5-Year Absence
2
Gluteus Maximus Muscle Shape Changes Tied to Aging, Frailty, and Type 2 Diabetes
3
FDA Approves Gene Replacement Therapy Itvisma for Patients With Spinal Muscular Atrophy
4
Durvalumab Receives FDA Approval for Resectable Gastric or Gastroesophageal Junction Adenocarcinoma
5
